[Nintedanib in the treatment of interstitial lung disease associated with systemic sclerosis: A justified hope?]
- PMID: 31477468
- DOI: 10.1016/j.revmed.2019.08.009
[Nintedanib in the treatment of interstitial lung disease associated with systemic sclerosis: A justified hope?]
Keywords: Interstitial lung disease; Nintedanib; Nintédanib; Pneumopathie interstitielle diffuse; Sclérodermie systémique; Systemic sclerosis.
Comment on
-
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112379 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical